{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 462094438
| IUPAC_name = 2-(dibutylamino)-1-[(9''Z'')-2,7-dichloro-9-(4-chlorobenzylidene)-9''H''-fluoren-4-yl]ethanol
| image = Lumefantrine-skeletal.svg
| width = 300

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|international|lumefantrine}}
| MedlinePlus = a609024
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = C
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 82186-77-4
| ATC_prefix = P01
| ATC_suffix = BF01
| ATC_supplemental =（和[[蒿甲醚|蒿甲醚]]的複方）
| PubChem = 6437380
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB06708
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4941944
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = F38R0JR742
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D03821
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 156095
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 38827

<!--Chemical data-->
| C = 30 | H = 32 | Cl = 3 | N = 1 | O = 1
| molecular_weight = 528.939 g/mol
| smiles = Clc1ccc(cc1)\C=C3\c4c(c2c(cc(Cl)cc23)C(O)CN(CCCC)CCCC)ccc(Cl)c4
| InChI = 1/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-
| InChIKey = DYLGFOYVTXJFJP-MYYYXRDXBY
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = DYLGFOYVTXJFJP-MYYYXRDXSA-N
}}

'''苯芴醇'''（'''Lumefantrine'''或'''benflumetol'''）是一種[[抗疟药|抗疟药]]，只會和[[蒿甲醚|蒿甲醚]]合併使用，稱為{{le|复方蒿甲醚-苯芴醇|Artemether/lumefantrine}}，有時也會用英文co-artemether表示<ref name="pmid17291911">{{cite journal |author = Toovey S, Jamieson A, Nettleton G |title = Successful co-artemether (artemether-lumefantrine) clearance of falciparum malaria in a patient with severe cholera in Mozambique |journal = Travel medicine and infectious disease |volume = 1 |issue = 3 |pages = 177–9 |year = 2003 |pmid = 17291911 |doi = 10.1016/j.tmaid.2003.09.002}}</ref>。

在1981年的[[青蒿素|青蒿素]]及其衍生物的全国指导委员会，授权中国军事医学科学院微生物与流行病学研究所教授周义清专攻蒿甲醚，他将[[蒿甲醚|蒿甲醚]]与苯芴醇联合用药，成为抗疟疾药中最有效的产品。<ref>{{cite journal |last1 = Makanga |first1 = Michael |last2 = Krudsood |first2 = Srivicha |title = The clinical efficacy of artemether/lumefantrine (Coartem®) |journal = Malaria Journal |year = 2009 |volume = 8 |issue = Suppl 1 |page = S5 |doi = 10.1186/1475-2875-8-S1-S5 |pmid = 19818172 |pmc=2760240}}</ref>。

== 相關條目 ==
* {{le|复方蒿甲醚-苯芴醇|Artemether/lumefantrine}}
** [[蒿甲醚|蒿甲醚]]

== 參考資料 ==
{{Reflist}}

{{Chromalveolate antiparasitics}}
<!--{{Antimalarials}}-->

[[Category:抗疟疾剂|Category:抗疟疾剂]]
<!--[[Category:Chloroarenes|Category:Chloroarenes]]-->
<!--[[Category:Fluorenes|Category:Fluorenes]]-->
[[Category:醇|Category:醇]]
[[Category:胺|Category:胺]]
<!--[[Category:Chinese_discoveries|Category:Chinese discoveries]]-->